229 related articles for article (PubMed ID: 34138486)
1. Anticancer activities, structure-activity relationship, and mechanism of action of 12-, 14-, and 16-membered macrolactones.
Wang R
Arch Pharm (Weinheim); 2021 Sep; 354(9):e2100025. PubMed ID: 34138486
[TBL] [Abstract][Full Text] [Related]
2. Discovery and Development of Macrolides as Anticancer Agents.
Liu R; Hou Y; Gu Y
Curr Top Med Chem; 2021; 21(18):1657-1673. PubMed ID: 34315371
[TBL] [Abstract][Full Text] [Related]
3. Coumarin-containing hybrids and their anticancer activities.
Zhang L; Xu Z
Eur J Med Chem; 2019 Nov; 181():111587. PubMed ID: 31404864
[TBL] [Abstract][Full Text] [Related]
4. β-Lactone Derivatives and Their Anticancer Activities: A Short Review.
Wang J; Shi Y; Jiang D
Curr Top Med Chem; 2021; 21(18):1645-1656. PubMed ID: 33797384
[TBL] [Abstract][Full Text] [Related]
5. Chalcone Derivatives and their Activities against Drug-resistant Cancers: An Overview.
Xiao J; Gao M; Diao Q; Gao F
Curr Top Med Chem; 2021; 21(5):348-362. PubMed ID: 33092509
[TBL] [Abstract][Full Text] [Related]
6. Artemisinin-derived hybrids and their anticancer activity.
Gao F; Sun Z; Kong F; Xiao J
Eur J Med Chem; 2020 Feb; 188():112044. PubMed ID: 31945642
[TBL] [Abstract][Full Text] [Related]
7. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
[TBL] [Abstract][Full Text] [Related]
8. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
Yang M; Liu H; Zhang Y; Wang X; Xu Z
Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
[TBL] [Abstract][Full Text] [Related]
9. Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010-2020).
Xiao J; Gao M; Sun Z; Diao Q; Wang P; Gao F
Eur J Med Chem; 2020 Dec; 208():112830. PubMed ID: 32992133
[TBL] [Abstract][Full Text] [Related]
10. 1,2,3-Triazole hybrids as anticancer agents: A review.
Alam MM
Arch Pharm (Weinheim); 2022 Jan; 355(1):e2100158. PubMed ID: 34559414
[TBL] [Abstract][Full Text] [Related]
11. Recent updates on 1,2,3-, 1,2,4-, and 1,3,5-triazine hybrids (2017-present): The anticancer activity, structure-activity relationships, and mechanisms of action.
Dong G; Jiang Y; Zhang F; Zhu F; Liu J; Xu Z
Arch Pharm (Weinheim); 2023 Mar; 356(3):e2200479. PubMed ID: 36372519
[TBL] [Abstract][Full Text] [Related]
12. Recent advances (2015-2016) in anticancer hybrids.
Kerru N; Singh P; Koorbanally N; Raj R; Kumar V
Eur J Med Chem; 2017 Dec; 142():179-212. PubMed ID: 28760313
[TBL] [Abstract][Full Text] [Related]
13. 1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships.
Xu Z; Zhao SJ; Liu Y
Eur J Med Chem; 2019 Dec; 183():111700. PubMed ID: 31546197
[TBL] [Abstract][Full Text] [Related]
14. Artemisinin-derived dimers as potential anticancer agents: Current developments, action mechanisms, and structure-activity relationships.
Zhang B
Arch Pharm (Weinheim); 2020 Feb; 353(2):e1900240. PubMed ID: 31797422
[TBL] [Abstract][Full Text] [Related]
15. Deoxyelephantopin and Isodeoxyelephantopin as Potential Anticancer Agents with Effects on Multiple Signaling Pathways.
Mehmood T; Maryam A; Ghramh HA; Khan M; Ma T
Molecules; 2017 Jun; 22(6):. PubMed ID: 28635648
[TBL] [Abstract][Full Text] [Related]
16. Heterochiral β-Peptide Polymers Combating Multidrug-Resistant Cancers Effectively without Inducing Drug Resistance.
Shao N; Yuan L; Ma P; Zhou M; Xiao X; Cong Z; Wu Y; Xiao G; Fei J; Liu R
J Am Chem Soc; 2022 Apr; 144(16):7283-7294. PubMed ID: 35420800
[TBL] [Abstract][Full Text] [Related]
17. Current scenario of indole derivatives with potential anti-drug-resistant cancer activity.
Jia Y; Wen X; Gong Y; Wang X
Eur J Med Chem; 2020 Aug; 200():112359. PubMed ID: 32531682
[TBL] [Abstract][Full Text] [Related]
18. Isatin-azole hybrids and their anticancer activities.
Hou Y; Shang C; Wang H; Yun J
Arch Pharm (Weinheim); 2020 Jan; 353(1):e1900272. PubMed ID: 31691360
[TBL] [Abstract][Full Text] [Related]
19. Coumarins as Potential Anti-drug Resistant Cancer Agents: A Mini Review.
Wang G; Sun S; Wu B; Liu J
Curr Top Med Chem; 2021; 21(19):1725-1736. PubMed ID: 33185162
[TBL] [Abstract][Full Text] [Related]
20. Chalcone hybrids as potential anticancer agents: Current development, mechanism of action, and structure-activity relationship.
Gao F; Huang G; Xiao J
Med Res Rev; 2020 Sep; 40(5):2049-2084. PubMed ID: 32525247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
